North Bridge Venture Partners VI L P, 10% Owner at Lyra Therapeutics, Inc. (LYRA), bought 3,610,832 shares at $2.43 ($8.8M) on 2023-05-31, disclosed to the SEC on 2023-06-02.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.43 | 197,946 | $481K | 5.5% |
| 2 | $2.43 | 197,946 | $481K | 5.5% |
| 3 | $2.43 | 403,858 | $981K | 11.2% |
| 4 | $2.43 | 403,858 | $981K | 11.2% |
| 5 | $2.43 | 1,203,612 | $2.9M | 33.3% |
| 6 | $2.43 | 1,203,612 |
| $2.9M |
| 33.3% |
| Total | $2.43 avg | 3,610,832 | $8.8M | 100% |